GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $48,281,000 | +597.3% | 222,597 | +271.0% | 0.60% | +1508.1% |
| Q4 2020 | $6,924,000 | +137.0% | 60,000 | +100.0% | 0.04% | -14.0% |
| Q3 2020 | $2,921,000 | +11.2% | 30,000 | 0.0% | 0.04% | -34.8% |
| Q1 2020 | $2,627,000 | +0.5% | 30,000 | +20.0% | 0.07% | +13.8% |
| Q4 2019 | $2,614,000 | +354.6% | 25,000 | +400.0% | 0.06% | +262.5% |
| Q3 2019 | $575,000 | -83.0% | 5,000 | -83.3% | 0.02% | -77.1% |
| Q1 2018 | $3,380,000 | – | 30,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |